SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-002796
Filing Date
2007-05-03
Accepted
2007-05-03 17:02:42
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 BIOGEN IDEC INC. b65131bie10vq.htm 10-Q 756425
2 EX-10.1 AMENDMENT DATED APRIL 4, 2006, TO 2005 OMNIBUS EQUITY PLAN b65131biexv10w1.htm EX-10.1 4627
3 EX-10.2 AMENDMENT DATED FEBRUARY 12, 2007, TO 2005 OMNIBUS EQUITY PLAN b65131biexv10w2.htm EX-10.2 4943
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO b65131biexv31w1.htm EX-31.1 8342
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO b65131biexv31w2.htm EX-31.2 8369
6 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b65131biexv32w1.htm EX-32.1 4076
  Complete submission text file 0000950135-07-002796.txt   788377
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 07816320
SIC: 2836 Biological Products, (No Diagnostic Substances)